Vimian acquires UK allergy business
The Vimian Group is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health. Vimian Group’s Specialty Pharma segment Nextmune has acquired the veterinary allergy division, Avacta Animal Health, from AvactaGroup plc.
Avacta Animal Health provides veterinary allergy diagnostic solutions through its laboratory in Wetherby (UK) and re-sells Nextmune’s immunotherapy products to veterinary clinics across the UK. The business division also provides testing kits to veterinary laboratories in other European countries. The acquisition is a carve-out from AvactaGroup plc, a UK-based company focused on diagnostic solutions for human health.
The business had revenues of GBP 1.6 million in 2021.
All news and storiesMore news
All news and storiesKEYTO Group establishes home security as a new business vertical
KEYTO Group continues to broaden its home services offering with a new vertical in home security. The first company to be added is the Swedish company Säkra Larm.
Read more →Audria expands into the UK with Tandem Property
Audria, a tech-driven real estate-services platform, expands into the UK with the addition of Tandem Property. Tandem Property provides property and asset management solutions, and is the fifth company to join Audria, following Newsec, Novier, Sveaviken and Avy.
Read more →Audria strengthens its real estate services offering with the addition of Novier
Audria, which brings together leading real estate services companies with a focus on technology, AI and international growth, strengthens its offering with the addition of Novier.
Read more →